ABSTRACT: An experiment was conducted to evaluate the effect of CLA on the immune response and performance of piglets when subjected to an immune challenge. A total of 32 weanling pigs (17 to 23 d of age) with an initial BW of 8.9 kg were allotted to a 3 × 2 factorial arrangement of treatments. There were 3 levels of dietary CLA (0%, 1%, and 2%) and 2 levels of lipopolysaccharide (LPS) challenge (unchallenged and challenged). Challenged pigs were challenged on d 7 and 21. On d 4 and 18, all pigs were inoculated with BSA for assessment of IgG production. There was no difference in growth performance among piglets receiving different CLA supplementation levels. However, LPSchallenged piglets had poorer BW (P < 0.05), ADFI (P < 0.01), and ADG (P < 0.001) compared with the control group at d 35 postweaning. Lipopolysaccharidechallenged piglets also had increased respiratory rate (P < 0.001) and rectal temperature (P < 0.001), and decreased plasma proteins, hematocrit, and white blood cell counts (P < 0.05). Production of IgG against BSA was increased in the 1% CLA supplementation group (P < 0.001), indicating that CLA has an immunomodulatory effect. Supplementation with CLA did not affect lymphocyte proliferation, percentage of CD4 + and CD8 + cells, plasma proteins, red and white blood cell count, respiratory rate, or rectal temperature after LPS challenge. Although CLA supplementation did not infl uence growth performance or certain immune system measurements, the increased IgG titers with 1% CLA dietary supplementation indicate that it has a benefi cial effect on the humoral immune system of weaned piglets.
INTRODUCTION
The term CLA refers to the positional and geometric isomers of linoleic acid (cis-9, cis-12 18:2). The CLA have conjugated double bonds that are separated by a single bond between 2 carbons. The 2 isomers most studied for biological activity are cis-9, trans-11, and trans-10, cis-12 (Pariza et al., 2001) .
Studies have shown that CLA is a nutraceutical with immunomodulatory capacity and dietary CLA may increase immunoglobulin production in piglets (Corino et al., 2009 ) and lymphocyte proliferation in dogs (Nunes et al., 2008) . Additionally, CLA can infl uence CD4 + and CD8 + subpopulation percentages in swine (DeVoney et al., 1997; Bassaganya-Riera et al., 2001 Lai et al., 2005) . The anti-infl ammatory properties of CLA are also evidenced in pigs and mice by decreasing proinfl ammatory cytokines in response to immune challenge Reynolds et al., 2009) .
The potential for CLA as a nutraceutical in feed supplementation is particularly promising when it comes to weanling piglets. Weaning is considered the most critical phase in swine because of food and environmental stressors that affect gastrointestinal tract development. During the onset of solid food intake, intestinal villi are damaged and infl ammatory processes occur (Hall and Byrne, 1989) . Reduced or absent antimicrobials in feed, along with intestinal mucosal injury, result in increased infection susceptibility and an increase in the incidence of diarrhea and death (Utiyama et al., 2006) .
In this study, we hypothesized that CLA supplementation may help combat the performance decline usually observed after weaning. Therefore, CLA supplementation and its effects on performance and immune response of lipopolysaccharide-(LPS) challenged piglets were evaluated.
MATERIAL AND METHODS
All procedures involving animals were in accordance with Brazilian guidelines and approved by the Ethics Committee of the Federal University of Rio Grande do Sul. The Brazilian guidelines are based on Federal Law N o . 11794 of October 8, 2008.
General Procedures and Experimental Treatments
Thirty-two weanling piglets, 17 to 23 d of age, were housed in metabolism cages located in a temperaturecontrolled room, providing thermal comfort to piglets throughout the experiment. Each cage represented the experimental unit. During the 4-d adaptation period, 2 piglets were housed in each cage to facilitate adaptation to their new environment. During the 35-d experimental period, the piglets were housed individually.
The study consisted of a 3 × 2 factorial, with 3 CLA supplementation levels (0, 1, or 2%) and the presence or absence of an immunological challenge. Immunological challenge was imposed on d 7 and 21. In total, 16 piglets were inoculated intramuscularly with 100 μg/kg of Escherichia coli LPS (serotype 055:B5; Sigma-Aldrich, St. Louis, MO), which was reconstituted in 1 mL of 0.01 M PBS with pH 7.4. The control piglets were inoculated with 1 mL of PBS (van Heugten et al., 1994) .
Individual BW, ADFI, ADG, and G:F were determined weekly. These responses were also determined 3 d after each LPS inoculation (van Heugten et al., 1994) .
Dietary Treatments
Two diets were offered throughout the experimental period, with a prestarter diet used on d 1 to 14 and a starter diet used on d 15 to 35. The diets were formulated with nutrient levels recommended by the Tabelas Brasileiras de Aves e Suínos (Rostagno et al., 2005) and differed only in the amount of added soybean oil and CLA-rich oil (Luta-CLA 60, BASF, Florham Park, NJ). The CLA-rich oil is produced by chemical isomerization of sunfl ower oil and consists of 61.5% CLA containing 50% cis-9, trans-11 isomer and 50% trans-10, cis-12 isomer. The remaining 38.5% of the CLA-rich oil consists of methyl ester of other fatty acids. The diets were formulated to contain 0%, 1%, or 2% dietary CLA (Table 1) .
Acquired Immunity Responses
Antibovine Serum Albumin IgG Production. On d 4 and 18, piglets were inoculated with 1 mg/kg intramuscularly of a BSA solution (A3912, Sigma-Aldrich) diluted in 0.5 mL PBS and 0.5 mL adjuvant (Li et al., 1999) . Complete Freund's Adjuvant (F5881, Sigma-Aldrich) was used in the fi rst inoculation and Incomplete Freund's Adjuvant (F5881 Sigma-Aldrich) was used in the second inoculation.
Blood samples were collected on d 4, 18, and 32. A Vacutainer tube was used to collect 4 mL of blood via the cranial vena cava (BD, São Paulo, Brazil). Blood samples were centrifuged at 2,000 × g for 15 min at 25°C. The ELISA plates in a 96-well format were coated with BSA (100 mL/well) at a concentration of 500 mg/mL in sodium carbonate buffer (0.2 M, pH 9.2). The plates were then incubated at 4°C for 16 h. Serum samples were tested in duplicate (100 mL/well, 1:15,000) and incubated for 2 h. The plates were incubated for 30 min with 100 mL of antipig IgG conjugated with peroxidase (1:5,000, A5670, Sigma-Aldrich). Then, 150 mL of ortho-phenylenediamine solution (002003, Invitrogen, Foster City, CA) was added and incubated for 15 min at 23°C. The reaction was then stopped with sulfuric acid (2 M, 50 mL/well). The anti-BSA IgG production was quantifi ed by optical density measurements performed with an ELISA plate reader (Anthos 2020, Biochrom, Cambridge, UK) at 492 nm. Between each step listed, plates were washed 3 times with PBS Tween-20 and all incubations were performed in a moist chamber at 37°C unless otherwise noted. To determine serum titer assays, a series of dilutions were tested and the lowest dilution presenting an optical density 2 SD above baseline was chosen.
Lymphocyte Stimulation Assay. On d 32, 4 mL of blood was collected from each animal via the cranial vena cava with heparinized Vacutainer tubes (150 units of sodium heparin, spray-coated; BD Biosciences, Franklin Lakes, NJ). Blood samples were diluted 1:2 in saline and 6 mL of diluted blood was carefully applied over a 4-mL layer of Histopaque (L2880, Sigma-Aldrich) in 15-mL conical tubes (Falcon, BD Biosciences). The tubes were centrifuged at 700 × g for 30 min at 25°C and the mononuclear layer was then collected with a Pasteur pipette. The mononuclear layer was washed 3 times by resuspending in Roswell Park Memorial Institute (RPMI) 1640 (Invitrogen) supplemented with antibiotics (100 IU/L penicillin, 100 mg/mL streptomycin) and centrifuging for 10 min at 700 × g at 25°C. The washed mononuclear cells were then resuspended in 2 mL RPMI 1640 supplemented with 0.05 mM 2-mercaptoethanol (Sigma-Aldrich), 100 IU/mL penicillin, 100 mg/mL streptomycin (Invitrogen), 2 mM L-glutamine (SigmaAldrich), and 10% pig serum. Cell counting and viability assessment was performed in a Neubauer chamber using trypan blue. For proliferation assays, mononuclear cells were plated in 96-well, microtiter, fl at-bottom plates at a concentration of 2.5×10 5 cells/well in 100 μL of complete RPMI medium. Either concanavalin A (Sigma-Aldrich, 5 μg/mL), BSA (A3912 Sigma-Aldrich, 100 μg/ mL), or RPMI 1640 were added to attain a fi nal volume of 200 μL. The plates were incubated at 37°C with 5% CO 2 . After 72 h, the plates were centrifuged for 10 min at 700 × g at 25°C, the supernatant was removed with a pipette, and 50 μL of thiazolyl blue tetrazolium bromide (2 mg/mL) (Sigma-Aldrich) was added to each well. The plates were incubated in an oven for 4 h and the plates were then centrifuged at 1,400 × g for 5 min at 25°C. The liquid was removed with a pipette and 100 μL of dimethyl sulfoxide (Sigma-Aldrich) was added to each well to solubilize any crystals formed. The plates were incubated for 20 min at 37°C and absorbance was measured with an ELISA reader (Anthos 2020) at 550 nm with a 620-nm reference fi lter. The stimulation index was calculated using the following formula: stimulation index = absorbance value of mitogen-stimulated culture ÷ absorbance value of unstimulated culture.
CD4 + and CD8 + Lymphocytes Subsets. On d 32, 4 mL of blood was aseptically collected via the cranial vena cava from each piglet into ethylenediaminetetraacetic acid Vacutainer tubes. The samples were centrifuged at 1,500 × g for 10 min at 25°C. The supernatant was removed and the cell pellet was treated with a hypotonic solution of NH 4 Cl to lyse erythrocytes. White blood cells were recovered by centrifugation (1,500 × g for 5 min at 25°C) and resuspended in PBS. Approximately 10 6 cells were incubated with fl uorochrome-labeled, monoclonal antibodies (Serotec Co., Sapporo, Japan) against pig CD4 + and CD8 + , which had been diluted 1:50 in PBS to achieve a total volume of 50 μL. The cells were incubated at 4°C for 30 min, washed 3 times, and resuspended in 500 μL of PBS. Flow cytometry was used to perform cell counts (Guava Technologies, Hayward, CA), using the gate from lymphocytes, based on forward scatter and side scatter measurements.
Acute Phase Response
Respiratory Rate and Rectal Temperature. As described by Ribeiro et al. (2010) , rectal temperature was measured before LPS challenge as a baseline measurement and again at 30, 60, 120, 150, 180, 210, 240 , and 270 min after LPS challenge on d 7 and 21. The respiratory rate was also measured 90 min after each LPS challenge.
Blood Count and Plasma Proteins. Blood was collected 180 min after LPS challenge on d 21 from all piglets via the jugular vein using vacuum system (BD). In total, 3 mL of ethylenediaminetetraacetic acid K2 blood was collected In the diets with 0% CLA, all vegetable oil was soybean oil; in the diets with 1% CLA, 1.63% soybean oil and 1.63% CLA-rich oil was used; and in the diets with 2% CLA, all vegetable oil used was CLA-rich oil.
for blood cell counts and 4 mL of blood without additives was collected for total protein determination. Blood smears were also collected and stained with Diff Quick (Laborclin, São Paulo, Brazil). Hematocrit was determined using the microhematocrit technique and total plasma proteins were measured by refractometry. Cell counts were performed manually in a hemocytometer (Neubauer Improved, New Optik, São Paulo, Brazil), using manual dilutions with 0.9% NaCl solution for erythrocyte counts and Türck solution (Newprov, Curitiba, Brazil) for leukocyte counts. The morphologic and differential leukocyte counts were performed by the same observer with an optical microscope (CX41 Olympus Inc., Center Valley, PA) The red blood cell indices, mean corpuscular volume, and mean corpuscular hemoglobin concentration were estimated using standardized formula (Thrall et al., 2004) . Finally, serum albumin, fi brinogen, and hemoglobin values were calculated using a standardized kit (Labtest, Belo Horizonte, Brazil) and a semiautomatic spectrophotometer (Metrolab 1600, Wiener, Buenos Aires, Argentina).
Statistical Analysis
Data were analyzed by ANOVA and Least Squares (LS) Means, using the Generalized Linear Model (GLM) procedure (SAS Inst. Inc., Cary, NC) appropriate for a factorial arrangement of treatments in a completely randomized design. The statistical model included the effects of immunological challenge (presence or absence of LPS challenge), CLA supplementation levels (0, 1, or 2%), and their interactions in the analyses of growth performance, anti-BSA IgG production, CD4 + and CD8 + lymphocytes subsets, blood cell counts, and plasma proteins. For respiratory rate, the day of immunological challenge (d 7 and 21) was also included in the model as a source of variation. For rectal temperatures, data were analyzed using a mixed model with repeated measures by the mixed procedure, using as sources of variation the immunological challenge (presence or absence of LPS challenge), CLA supplementation levels (0, 1, or 2%), minutes after challenge, and all interactions. During the experimental period, 3 piglets were lost and their data were included in the analyses until that moment. Pooled SEM was calculated by averaging the SEM calculated with the GLM procedure of SAS for the variable of interest. A level of P ≤ 0.05 was used to indicate statistical signifi cance.
RESULTS AND DISCUSSION

Performance
The results of LPS challenge on performance are shown in Table 2 and Figure 1 . During the week when piglets were subjected to the immunological challenge (beginning with d 7 and 21), those piglets stimulated with LPS had less ADFI (P < 0.05), less ADG (P < 0.01), and poorer G:F (P ≤ 0.05). However, the week after LPS challenge, ADG and ADFI were not different between LPS-challenged and unchallenged pigs. These results indicated that the depression in growth induced by LPS lasts only ∼1 wk, after which time effects of LPS disappear. Nevertheless, the negative effect of LPS on these responses is evident when analyzing the prestarter period (d 1 to 14), starter period (d 15 to 35), and total experimental period (d 1 to 35) . When the BW values at 35 d postweaning were compared, it was apparent that the immune-challenged animals could not compensate for the performance decline after LPS exposure and consequently had less BW values at d 35 (P < 0.05). Similar results were observed by Zhao et al. (2005) and Liu et al. (2008) , who used the same LPS dose as in this experiment and van Heugten et al. (1994) who used twice the LPS dose (200 μg/kg). The consistent results with this experimental model indicate that LPS challenge is an effi cient model of stress on animal immune systems.
Lipopolysaccharide molecules are effective in stimulating proinfl ammatory cytokine (i.e., IL-1, IL-6, and TNF-α) production (Tizard, 2009) and these cytokines are the major mediators of intermediary metabolism in immunologically challenged animals (Klasing, 1988) . Johnson (1997) suggested that the anorectic and metabolic effects that can occur in this situation are partially because of an immunological mechanism, in addition to direct effects of infectious pathogens. This fact is supported by experiments demonstrating that several infl ammatory agents reduced ADFI and G:F, increased body temperature, and increased plasma corticosterone (Klasing et al., 1987; Klasing and Barnes, 1988) . The immune response can cause tissue damage and decrease muscle tone and cardiac output, which results in hypotension, poor tissue perfusion, and subsequent cell death (Machado et al., 2004) . One hypothesis for the anti-infl ammatory effect of CLA is that supplementation results in increased antigen receptors that regulate genes involved in immune function. One such receptor may be PPARγ (O'Shea et al., 2004) . This receptor is capable of inhibiting TLR-4 receptor expression on monocytes, which recognize LPS (Reynolds et al., 2009) . Moreover, in studies with pigs, CLA was responsible for preventing increases in serum proinfl ammatory cytokines (Bassaganya-Riera et al., 2003; O'Shea et al., 2004; Lai et al., 2005; Zhao et al., 2005) and promoting increases in IL-10 expression, which is the main anti-infl ammatory cytokine .
Contrary to the hypothesis mentioned, Table 2 shows no effect of CLA supplementation and LPS challenge on piglet growth performance, which indicates that dietary CLA did not reverse the stress caused by LPS. Additionally, there was no difference in performance with the differ-ent levels of CLA supplementation. Zhao et al. (2005) did not observe anticatabolic CLA effect (2% dietary supplementation) in weanling piglets challenged with the same LPS dose used in the present experiment (100 μg/kg). It is possible that if a reduced dose of LPS had been used, the dietary CLA might have reversed or limited the effects of the acute phase response. However, in broiler chickens, 1% supplementation with dietary CLA prevented decreased ADFI after a single challenge with 1,500 mg/ kg of LPS and also prevented reduction in ADG and G:F after 3 consecutive challenges on alternate days with 200 mg/kg LPS (Takahashi et al., 2002) . However, CLA did not affect the performance of animals that did not receive LPS challenge, indicating that the anticatabolic effect may occur only when there is an immune system challenge. Interestingly, CLA prevented growth performance decline in broiler chickens (Takahashi et al., 2002 ) that were challenged with a much larger dose of LPS than what was used in the piglets.
Acquired Immunity Responses
Anti-BSA IgG Production. Dietary supplementation with 1% CLA increased anti-BSA IgG production (P < 0.001; Table 3 ), regardless of whether the animal was stimulated with LPS. The greater value of optical density indicates that more IgG was produced in response to the antigen. Results of other experiments have indicated that dietary CLA increases antigen-specifi c immunoglobulin production in pigs and birds (He et al., 2007) , and total immunoglobulin production in humans (Song et al., 2005) and rats (Ramírez-Santana et al., 2009). A maternal effect was also ob- served by Corino et al. (2009) , who reported that piglets weaned from sows fed a diet supplemented with 0.5% CLA had greater BW and increased total IgG production than pigs weaned from sows that did not receive dietary CLA. This response may be important for newborn animals that have yet to develop specifi c immune response mechanisms.
The mechanism by which CLA affects immunoglobulin synthesis is unclear but a possible explanation is that dietary CLA infl uences IL production. In previous experiments, IL-2 increased IgG, IgA, and IgM synthesis (Kawano and Noma, 1996) , whereas results of other experiments indicate that IL-4 increased IgE synthesis (Pène et al., 1988) . Because CLA can stimulate IL-2 production and simultaneously reduce IL-4 (Yang and Cook, 2003) , it is possible that CLA can indirectly promote IgG, IgA, and IgM synthesis, while decreasing IgE levels.
The intermediate CLA level increased anti-BSA IgG production. When it comes to an immunological measurement, it is not always the greater concentration of nutraceutical supplementation that promotes the strongest immune responses. Silva et al. (2009) tested 3 dietary vitamin E levels (30, 65, and 100 mg/kg) for broiler chickens and observed that the intermediate concentration promoted the greatest antibody production against Newcastle disease.
The CLA may also reduce arachidonic acid concentrations in cell membrane phospholipids and consequently reduce eicosanoid production derived from n-6 PGE 2 and leukotriene (LT) B 4 . This effect indirectly increases the n-3-derived eicosanoids (PGE 3 and LTB 5 ) because both fatty acids compete for the same enzymes (He et al., 2007) . The ratio between eicosanoids directly infl uences the immune system and an imbalance can generate different results. This fact may explain why the 1% CLA supplementation results in a better humoral response than no supplementation or 2% CLA supplementation.
Lymphocyte Stimulation and CD4 + and CD8 + Lymphocytes Subsets. Although dietary supplementation with 1% CLA affected the humoral response to BSA, this nutrient was not effective in infl uencing cellular immune response. Protein antigens, like BSA, are not good inducers of cell-mediated immunity (Tizard, 2009 ) and possibly this is the reason why there was no difference among treatments in terms of lymphocytes stimulation (Table 3) .
Lymphocyte proliferative capacity of rats fed diets containing 1% CLA is not different from that of rats or broilers fed diets containing no CLA on d 21 (Zhang et al., 2005; Ramírez-Santana et al., 2009 ), but inclusion of 1% CLA in diets fed to broilers increased lymphocyte proliferative capacity on d 42 compared with broilers fed no CLA (Zhang et al., 2005) . Bassaganya-Riera et al. (2001) and Lai et al. (2005) , who both worked with pigs, and Nunes et al. (2008) , who worked with dogs, observed an increase in lymphocyte stimulation in response to dietary CLA.
There was no difference in the percentage of CD4 + or CD8 + lymphocytes subsets at d 32. By contrast, Bassaganya-Riera et al. (2001) Lai et al. (2005) proposed that CD8 + lymphocytes numerically represent the largest lymphocyte subpopulation in porcine blood and the type of dietary immune enhancement induced 1 There were 5 piglets/treatment, except the treatments without CLA supplementation, which had 6 piglets/treatment.
2 Escherichia coli LPS challenges were performed on d 7 and 21. by CLA may depend on the function of cells expressing CD8 + . In birds, CLA increased CD4 + cells but not CD8 + cells (DeVoney et al., 1997) . To some extent, the type of dietary immune enhancement induced by CLA may depend on the function of cells expressing CD8 + that are most affected by dietary CLA. The reported effects of CLA on the immune system range from stimulation to inhibition and lack of infl uence (Bassaganya-Riera et al., 2001) . These discrepancies can be attributed to factors like the cell culture condition (e.g., serum and mitogen concentration, and cultivation time), cell type (e.g., peritoneal, splenic, and peripheral), diet composition, species, and age (Zhang et al., 2005) . Moreover, the prevalent CLA isomer in the mixture and dietary supplementation level may also determine the biological activity (Pariza et al., 2001 ).
Acute Phase Response
Rectal Temperature. As expected, LPS challenge induced signs of acute bacterial infection with consequent anorexia and increased rectal temperature ( Figure  2 ), similar to the results observed in Klasing (1988) and Liu et al. (2008) . The anti-infl ammatory effect of CLA (Pariza et al., 2000 , O'Shea et al., 2004 Reynolds et al., 2009 ) may attenuate the increased rectal temperature by LPS-challenged piglets; however, none of the tested CLA supplementation levels affected the rectal temperature (data not shown). Rectal temperature varies with individual animal and, generally, rectal temperature readings have very high CV, which complicates statistical analysis. Increased rectal temperature values were noted for control piglets during the fi rst measurement.
Respiratory Rate. Further indicating that CLA supplementation did not reverse the stress caused by LPS, no relationship was observed between CLA supplementation level and respiration rate at 90 min after LPS challenge (Table 3) . However, greater respiratory rates were recorded in LPS injected piglets, which is in agreement with the fi ndings in Ribeiro et al. (2010) .
Larger increases in respiratory rates were reported after the second LPS inoculation (P < 0.01) and is indicative of receptor presensitization to LPS. This result can be explained by a Type I hypersensitivity immune response, which is characterized by allergic anaphylaxis. In Type I reactions, B cells react by secreting IgE after initial exposure to an antigen. When animals are exposed again to the same antigen, it binds to IgE antigen receptors and results in release of substances such as histamine, serotonin, eosinophilic chemotactic factors of anaphylaxis, platelet activating factor, prostaglandins, and leukotrienes (Banks, 1991) . These substances increase vascular permeability, leading to intense plasma exudation and generalized edema. Systemic and pulmonary hypotension ensues, which can result in dyspnea and even death (Tizard, 2009) . Erythema, salivation, and vomiting are also signs of Type I reactions; these signs were presented by several experimental piglets. Three of these piglets, 1 from each treatment group, died from their reaction.
The enhanced reaction that was observed after the second inoculation did not translate into markedly reduced performance values. Moreover, the deleterious effect was not cumulative, as evidenced by similar ADFI and ADG values in challenged and unchallenged piglets in the week after the second inoculation. Also, no compensatory effect in challenged piglets was observed because the performance returned to the same level of the controls.
Blood Count and Plasma Proteins. When CLA supplementation levels were compared, no difference in plasma proteins (Table 4 ) or blood count (Tables 4 and  5) were noted. Even with LPS challenge, differences in these values were within the reference limits for pigs. However, the LPS-challenged group had decreased values, below those considered normal, for total plasma protein (P < 0.01), leukocytes (P < 0.001), and neutrophils (P ≤ 0.01).
The reduction in total plasma protein is expected in acute infl ammatory reaction cases (Silva et al., 2005) and is consistent with the fi ndings in Ribeiro et al. (2010) . Globulin, albumin, and fi brinogen are the major plasma proteins and were comparatively decreased in LPS-challenged piglets (P < 0.001). In addition to increased body temperature in the acute infl ammatory response, there is also activation of protein catabolism and reduction of plasma total protein to provide AA for gluconeogenesis (Kaneko et al., 1997) . Thus, there is a decrease in plasma osmolality, resulting in a net output from the bloodstream to the tissues. This change promotes hemoconcentration and is compatible with the greater hematocrit (P < 0.05) and red blood cell (P < 0.05) values noted in the LPSchallenged group.
Leukopenia is one of the most important and characteristic effects of exposure to an endotoxin such as LPS (Schade, 1989) . In this study, the decrease in white blood cells (P < 0.001) was due to neutropenia (P ≤ 0.01) and fewer lymphocytes (P ≤ 0.01) in the LPS-challenged group. The greater number of eosinophils (P ≤ 0.01) in this group is consistent with the hypersensitivity reaction discussed earlier.
The CLA supplementation at 1% in weanling piglets resulted in a benefi cial effect as detected by IgG anti-BSA production. Thus, CLA is a nutraceutical that enhances humoral immunity, but CLA greater than 1% may suppress antibody production. Other immunological variables, along with growth performance, were not affected by dietary CLA even in the presence of LPS challenge.
This result indicates that CLA was not effective in reversing or ameliorating the stress induced by LPS.
A LPS was an effi cient experimental model to induce immunological stress. However, it is possible that 100 mg/kg LPS was too great a dose and caused stress beyond the ability of CLA to affect other variables. 1 There were 5 piglets/treatment, except the treatments without CLA supplementation, which had 6 piglets/treatment.
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